The Drug-Induced Respiratory Disease Website
The broad term 'cardiotoxicity' encompasses several entities and patterns of cardiac injury including subclinical change in LVEF or cardiac biomarkers, cardiomyopathy, heart failure, AV heart block, conduction abnormalities, myocarditis, myocardial fibrosis, dysrrhythmias, pericarditis, pericardial effusion, tamponade, syncope, cardiac/cardiopulmonary arrest and/or valvular heart dysfunction or disease. Pulmonary edema and pleural effusion may be the annunciating signs and symptoms of cardiotoxicity (PMID 1403060). Cardiotoxicity is a significant hurdle of novel anticancer agent use including the immune checkpoint inhibitors (PMID 25210198, 25574894, 27732808, 29912044, 29980467, 30433897). Can be life-threatening or fatal (PMID 29980467)
Publications
Loperamide abuse cardiotoxicity. Should loperamide still be an over the counter medication?
The American journal of emergency medicine 2018 Sep;36;1716.e1-1716.e3 — 2018 Sep — 1716.e1-1716.e3
Loperamide cardiotoxicity: "A Brief Review".
Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 2018 Mar;23;e12505 — 2018 Mar — e12505